课题基金 / 基金详情

CRYPTOCOCCUS NEOFORMANS--A MODEL FOR PATHOGENIC FUNGI

CRYPTOCOCCUS NEOFORMANS--A MODEL FOR PATHOGENIC FUNGI
新型隐球菌——病原真菌的模型
批准号:
6632070
负责人:
John R. Perfect
金额:
$91.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2005-02-28

项目摘要

项目成果

John R. Perfect的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This program project for a medical mycology unit is focused on an interdisciplinary research approach to increase our understanding of the pathobiology of medically important fungi through the model pathogen, Cryptococcus neoformans. In this proposal we will use interrelated molecular biological approaches to identify and validate targets for the development of diagnostics, vaccines and therapeutics. To achieve these goals, the proposal has been divided into four distinct but interconnected projects which focus on Cryptococcus neoformans as a model system for pathogenic fungi. Project 1 is the genotype and phenotypic evolution of C. neoformans. In these population studies, the general importance and validity of drug targets can be determined; identification of yeast strain drift can be assessed which may affect vaccine development and help molecular diagnostics to interface with prognostic factors. Project 2 will study signal transduction pathways regulating virulence in C. neoformans. In this proposal, both conserved and unique features will be dissected to allow these central pathways for gene expression to be exploited for antifungal drug targets. Project 3 concerns genetic identification of antifungal drug targets in C. neoformans. With the use of saccharomyces cerevisiae as a surrogate, exploration into essential genes for temperature growth and requirements for amino acids and vitamins in C. neoformans will be performed. Project 4 is the genetic controls for host temperature growth in C. neoformans. In many respects the most simple but important virulence phenotype of C. neoformans (growth at 37 degrees Celsius) will be explored. In this project, a direct analysis of genes necessary of genes necessary or essential for growth at 37 degrees Celsius will be identified. A virulent mutants created from experiments in Projects 2-4 can be used either for live vaccines or tools for screening combinatorial libraries made on-campus for leads to antifungal compounds. This program emphasizes a focus on a single pathogen with a basic but broad-spectrum and highly interactive genomic approach to scientific investigations which can be extrapolated to other fungi.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution.
一项随机比较研究,以确定奥美拉唑对伊曲康唑口服溶液血清峰浓度的影响。
DOI: 10.1093/jac/dkg089
发表时间: 2003
期刊: The Journal of antimicrobial chemotherapy
影响因子: --
作者: [Johnson,MelissaD, Hamilton,CarolD, Drew,RichardH, Sanders,LindaL, Pennick,GennethelJ, Perfect,JohnR]
通讯作者: Perfect,JohnR
Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant.
新型隐球菌 MET3 基因和 met3 突变体的分子和遗传分析。
DOI: 10.1099/00221287-148-8-2617
发表时间: 2002
期刊: Microbiology (Reading, England)
影响因子: --
作者: [Yang,Zhonghui, Pascon,RenataC, Alspaugh,Andrew, Cox,GaryM, McCusker,JohnH]
通讯作者: McCusker,JohnH
Agents for treatment of invasive fungal infections.
用于治疗侵袭性真菌感染的药物。
DOI: 10.1016/s0030-6665(00)80005-5
发表时间: 2000
期刊: Otolaryngologic clinics of North America
影响因子: 1.7
作者: [Luna,B, Drew,RH, Perfect,JR]
通讯作者: Perfect,JR
Administrative Core
  • 批准号:
    8931200
  • 项目类别:
  • 资助金额:
    $9.05万
  • 财政年份:
    2015
  • 负责人:
    John R. Perfect
  • 依托单位:
Transdisciplinary Program to Identify Novel Antifungal Targets and Inhibitors
  • 批准号:
    9272329
  • 项目类别:
  • 资助金额:
    $180.35万
  • 财政年份:
    2015
  • 负责人:
    John R. Perfect
  • 依托单位:
Evolution of Cryptococcus neoformans strains from patients with HIV/AIDS
  • 批准号:
    8511334
  • 项目类别:
  • 资助金额:
    $42.87万
  • 财政年份:
    2011
  • 负责人:
    John R. Perfect
  • 依托单位:
Evolution of Cryptococcus neoformans Strains from Patients with HIV/AIDS
  • 批准号:
    10199975
  • 项目类别:
  • 资助金额:
    $37.42万
  • 财政年份:
    2011
  • 负责人:
    John R. Perfect
  • 依托单位:
海外基金